Dr. April Lovelady is an innovator, entrepreneur, and educator with over a decade of experience at the intersection of healthcare, engineering, and business. Early in her career, she worked for NASA, where she played a crucial role in capturing customer requirements and converting them into tangible products for the Space and Life Sciences Program. She has since transitioned into academia, where she has designed and taught courses that focus on integrating the entrepreneurial mindset into the STEM curriculum through experiential and project-based learning. With a passion for translating ideas into impact, she specializes in bridging the gap between scientific discovery and clinical application.
Dr. Lovelady holds a PhD in Engineering and a Master’s in Clinical Translation Management, with expertise in turning laboratory discoveries into medical devices, therapeutics, and clinical innovations for patient care. She has co-founded two medical device companies, including Voyager Biomedical, which is currently enrolling patients in a clinical trial to advance vascular access technologies.
Her entrepreneurial journey includes serving as a National Science Foundation (NSF) I-Corps team member, where she honed her skills in customer discovery and market validation. She volunteers with the University of Texas HUB Incubator, supporting early-stage ventures in refining their business models and commercialization strategies.
Before joining Texas A&M’s School of Engineering Medicine (EnMed), Dr. Lovelady led interdisciplinary student teams from engineering, nursing, and business on global study abroad programs designed to expose future innovators to healthcare systems and entrepreneurship outside the United States.
At EnMed, she now serves as Director of Innovation Immersion Experiences, helping launch EnGen, a new business incubator created to support innovators as they translate ideas into clinical solutions. Through EnGen and her broader leadership, Dr. Lovelady is committed to fostering a culture of innovation that equips students, clinicians, and researchers to bring meaningful technologies to market and improve patient care worldwide.